Atai Life Sciences N.V.

NASDAQ:ATAI

1.5 (USD) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -38.991-27.033-57.312-26.713-18.29243.373-33.772-34.354-46.649-35.701-37.509-37.558-93.273-31.642-53.3734.044-94.355-83.194-16.95615.88
Depreciation & Amortization 0.2250.0830.0820.0830.1010.0740.0790.0650.0530.0360.0190.060.029-0.0070.0190.0060.0140.0050.0030.002
Deferred Income Tax 0000-8.497-70.8881.40505.07400052.874-3.373-12.0281.6622.64161.8739.822-17.99
Stock Based Compensation 8.4025.0466.2825.767.3058.2538.7628.66212.1410.5159.51210.20813.39812.2437.5120.21264.9372.1390.0410.041
Change In Working Capital -4.0352.1252.889-5.0142.5650.3410.8313.66-4.0450.0342.129-1.4530.278-4.86220.266-23.2864.042-0.0830.4740.017
Accounts Receivables 000-1-2.01400000000020-200000
Change In Inventory 00000000000000000000
Change In Accounts Payables -2.1331.022-0.019-0.742-0.991.693-1.0732.476-0.5980.155-0.705-1.8863.971-4.051-1.4313.8111.0620.390.0250.227
Other Working Capital -1.9021.1042.907-4.2723.555-1.3521.904-2.476-3.447-0.1212.8340.433-3.693-0.81121.697-27.0972.98-0.4730.449-0.21
Other Non Cash Items 10.1040.43831.8319.979-4.2830.4160.0810.8562.922-2.9293.9184.7576.185-0.4669.5010.83816.50713.8151.398-1.839
Operating Cash Flow -24.295-19.341-16.228-22.573-21.101-18.431-22.614-21.111-30.505-28.045-21.931-23.986-20.509-28.111.897-16.524-6.214-5.445-5.218-3.889
Investing Activities:
Investments In Property Plant And Equipment -0.0060.0050-0.005-0.01-0.002-0.128-0.443-0.223-0.529-0.216-0.056-0.357-0.318-0.278-0.175-0.05-0.001-0.003-0.005
Acquisitions Net 0.3590000.0370.0020.1570171.116-94.0550-211.68-47.575-0.003-4.891-0.468-2.088-5.341-0.092-17.731
Purchases Of Investments -596.924-65.56-31.364-5.319-138.154-39.6170-52.504-27.476-17.998-211.680.001-0.214-22.683-0.762-0.756-5.341-0.092-17.731
Sales Maturities Of Investments 11.29-55.66484.26143.8417.00593.64817.7419.461132.77994.055002.417-0.495-0.155005.3410.09217.731
Other Investing Activites -0.083-16.425-2.4-1.001-1.902-1.979-0.157-3-171.11694.0550.077-3-3.1190.416-0.301-2.316-0.972-0.034-0.211-0.987
Investing Cash Flow 6.5624.8416.30111.471-0.189-46.485-22.00516.01880.05266.05-18.214-214.736-48.633-0.614-28.308-3.721-3.866-5.376-0.306-18.723
Financing Activities:
Debt Repayment 00000000015000.001-0.001-1.5853.1731.43118.0613.2049.807
Common Stock Issued 0-0.3250.32500.016-00.0010.2064.636-1.0771.0770.1320.817-8.785381.51428.3782.439000
Common Stock Repurchased 00000000000000000000
Dividends Paid 00000000000000000000
Other Financing Activities 0.1544.8940.3260-8.4770-0.1010.206-1.2524.7811.7940.1321.7223.878-6.166-1.044-1.89000
Financing Cash Flow 0.1544.8940.3260-8.461-0-0.10.206-0.92219.7811.7940.1321.7233.877373.76330.49981.9818.0613.2049.807
Other Information:
Effect Of Forex Changes On Cash 0.1230.2370.066-0.064-0.2120.318-0.0760.159-0.5510.621-1.4920.299-0.6231.5331.901-3.1312.6360.7370.108-0.312
Net Change In Cash -17.45810.630.466-21.167-31.458-64.598-44.795-4.72848.07458.407-39.843-238.291-68.042-23.314349.2537.12374.5367.977-2.212-13.117
Cash At End Of Period 27.50544.96334.33323.86745.03476.492141.09185.885190.613142.53984.132123.975362.266430.308453.622104.36997.24622.7114.73316.945